ZURICH -Novartis said on Monday it was integrating its pharmaceuticals and oncology units into an innovative medicines business to simplify its structure, targeting savings of at least $1 billion by.
Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis announces new organizational structure to accelerate growth, strengthen pipeline and increase productivity